FDA Drug Recalls

Recalls / Class II

Class IID-0666-2017

Product

ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by MEDISCA INC. PLATTSBURGH, NY Product Code 2261

Affected lot / code info
a) 129669/C, 129669/F, 129669/H, 129669/J, 130941/B 130941/D, 130941/F, 136108/B, 139091/B; b) 129669/B, 129669/E, 130941/A, 130941/C, 130941/E,130941/G, 136108/A,

Why it was recalled

cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Recalling firm

Firm
Medisca, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
661 State Route 3 Unit C, N/A, Plattsburgh, New York 12901-6531

Distribution

Quantity
N/A
Distribution pattern
Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom

Timeline

Recall initiated
2017-04-03
FDA classified
2017-04-12
Posted by FDA
2017-04-19
Terminated
2019-06-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0666-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.